None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Inpatients who underwent primary unilateral hip replacement in our department from September 1, 2016 to November 30, 2019; 2. Patients receiving both TXA regimens; 3. Preoperative hemoglobin level >90g/L; 4. Preoperative Doppler ultrasound examination of lower limbs was negative.
Exclusion criteria
Exclusion criteria: 1. Revision hip arthroplasty; 2. Underwent tumor-related hip replacement; 3. Complicated with severe liver and renal failure; 4. Coagulopathy; 5. History of venous thromboembolism within 6 months after admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hidden blood loss (HBL);Hemoglobin decline in value;Thromboelastography; | — |
Secondary
| Measure | Time frame |
|---|---|
| Routine fibrinolysis index (FDP, D-D);Routine coagulation indexes (PT, APTT);Gender;Age;Height;Weight;Major diagnosis;Surgical side (left / right);Intraoperative blood loss;Operation time;Length of stay; | — |
Countries
China